Human Papilloma Virus (HPV) self-sampling: do women accept it?

Area of Science:

• Gynecology
• Public Health
• Molecular Diagnostics

Background:

• Cervical cancer screening programs often rely on Pap smears.
• Human Papilloma Virus (HPV) self-sampling offers a potentially more accessible screening method.
• Understanding women's acceptance and willingness to purchase HPV self-sampling kits is crucial for implementation.

Purpose of the Study:

• To assess the acceptability of HPV self-sampling among women aged 28-60.
• To identify factors influencing the willingness to purchase HPV self-sampling kits.
• To evaluate the potential of HPV self-sampling in cervical cancer screening programs.

Main Methods:

• 164 women underwent HPV self-sampling using the Digene HC2 DNA collection kit.
• Participants completed self-administered questionnaires post-sampling.
• Data analysis focused on acceptability, ease of procedure, pain, concerns, and purchase intent.

Main Results:

• High acceptability of HPV self-sampling was observed, with most finding it easy and experiencing minimal pain.
• The primary concern was obtaining a sufficient sample quality (90.1%).
• While over 90% were willing to perform self-sampling, only 70% intended to purchase a kit, indicating cost as a barrier.

Conclusions:

• HPV self-sampling is a viable and acceptable option for cervical cancer screening.
• Cost is a significant factor affecting the uptake of HPV self-sampling kits.
• Future research should explore rural populations and those with low Pap smear adherence, while clinicians should address cost barriers.